J&J Expects Inflation, China COVID Hit To Carry Into 2023

Johnson & Johnson on Tuesday said it sees the impact from high inflation carrying into 2023 and expects China's major COVID-19 outbreak to dent sales at its medical devices unit in the first half

Related Keywords

China ,United States ,Richard Newitter ,John Boylan ,Joseph Wolk ,Edward Jones ,Jj Pharmaceuticals Unit ,Truist Securities ,Wall Street ,Financial Officer Joseph Wolk ,Pharmaceuticals Unit ,Business , ,